REDS LEGEND ERIC DAVIS IS MAKING A DIFFERENCE TO ZAP SOME DEADLY STATISTICS. MORE THAN 53,000 AMERICANS WILL DIE THIS YEAR ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Weight-loss drugs linked to dramatically lower death rates in colon cancer patients - GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the ...

New results from a multicentre clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and ...